The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASH 2018 | Association between depth of response and survival in Waldenström’s
Deep responses are associated with longer disease-free survival in a variety of hematologic malignancies; however, this data is limited in Waldenström’s Macroglobulinemia (WM). Jonas Paludo, MD, of the Mayo Clinic, Rochester, MN, discusses the impact of depth of response on disease-free and overall survival in WM. This interview took place at the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA.
